Archive: Publications
-
RFK’ Jr.’s Immunity to Scientific Evidence is Dangerous: Co-Director Comments
As a physician with a long career in alternative medicine and who opposes pharmaceutical marketing, you might think I have a lot in common with Robert F Kennedy Jr. You’d be wrong. Dr. Adriane Fugh-
Category: News
-
A Hard Look at Prescribing: Program Co-Director Comments on New Opioid Study
This February, Program Co-Director Adriane Fugh-Berman and her colleague, Judy Butler, authored an article breaking down a new study on opioid prescribing and use disorders. According to the research
Category: News
-
History Repeating? Program Co-Director Comments on “Non-Addictive” Pain Pill in The Washington Post
This week, Dr. Adriane Fugh-Berman, Co-Director of the M.S. HAPI program, commented on a new pain pill set for FDA review this January. The drug is non-opioid and aims to be an alternative to pre
Categories: Announcements, News
-
Advocacy in Action: PharmedOut Organizes a Letter Challenging “Dangerous Disinformation”
A recent STAT news article covers Program Co-Director Dr. Adriane Fugh-Berman's organization, PharmedOut, which has organized a letter signed by multiple experts on women's health "demanding that the
Category: News
-
“80% of Adolescents” at Risk: The Hoya Features HAPI Seminar in New Article
The Hoya, Georgetown’s student newspaper, published an article on a HAPI seminar featuring Dr. Charles Hillman on Physical Activity, Adiposity, and Brain Health in Children. The recap covers his pres
Category: News
-
“A New Dystopic Era”: Dr. Fugh-Berman on Pharmaceutical Companies Selling Direct
Dr. Fugh-Berman and her colleague at PharmedOut, Judy Butler, have just published an opinion piece in STAT news on an alarming new pharmaceutical practice: selling prescription drugs directly to cons
Category: News
-
Peer Reviewers Made $1 Billion in 3 Years: Dr. Fugh-Berman Featured in MedPage Today on Medical Journal Financial Conflicts
More than half of peer reviewers for four top medical journals received payments from drug and medical device manufacturers, totaling $1.06 billion, from 2020 to 2022, according to an analysis of th
-
Drug Company Tricks: Patricia Bencivenga ’21 publishes Op-Ed in the Pittsburgh Post-Gazette
Patricia Bencivenga '21 recently published an Op-Ed in the Pittsburgh Post Gazette alongside Judy Butler on "Drug company tricks: Gaslighting the worried well into becoming the worried sick." Patrici
Category: News
-
Dangerous Fentanyl “Candy” Off the Market: Program Co-Director Adriane Fugh-Berman Published in The Kansas City Star
Last week, Program Co-Director Adriane Fugh-Berman published an opinion piece with PharmedOut colleague Judy Butler in The Kansas City Star. The piece covers the rise and fall of fentanyl lollipops,
Categories: News, News Story
-
Reproductive Justice: The Hoya Highlights Health and the Public Interest Seminar with Dr. Marea
On September 20th, The Hoya, Georgetown’s oldest and largest student newspaper, published an article highlighting a recent seminar hosted by the M.S. Health and the Public Interest program, titled “Operationalizing Reproductive Justice in Health Services Research and Policy To Address Perinatal Health Disparities.”
Category: News